More on QNCX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.6 Score)

Upcoming Events

- Earnings (8/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Quince Therapeutics (NQ:QNCX)
Delayed: 17.86 --0 (-0%)
Prev. Close $17.86  
Open$17.86 
52 Wk High$ 
52 Wk Low$ 
Day High$17.86 
Day Low$17.86 
P/E N/A  
EPS$ 
Volume183 

Friends, Peers and Foes (?): OPCH (more...)

Jun 30, 2026 08:02 AM Quince Therapeutics forms pulmonary medicine advisory board for LAM-001
Jun 30, 2026 08:01 AM Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board
Jun 26, 2026 04:31 PM Form 8-K/A Quince Therapeutics, For: Jun 26
Jun 26, 2026 09:18 AM Form 8-K Quince Therapeutics, For: Jun 26
Jun 25, 2026 07:28 AM Quince Therapeutics (QNCX) Reiterated at Overweight by Cantor Fitzgerald
Jun 25, 2026 07:28 AM Quince Therapeutics (QNCX) Reiterated at Overweight by Cantor Fitzgerald Post Orphai Acquisition
Jun 24, 2026 06:10 AM Leerink Starts Quince Therapeutics Inc. (QNCX) at Outperform
Jun 23, 2026 06:13 AM Cantor Fitzgerald Starts Quince Therapeutics Inc. (QNCX) at Overweight
Jun 15, 2026 05:57 PM Form 4 Quince Therapeutics, For: Jun 11 Filed by: Lamond David
Jun 15, 2026 05:52 PM Form 4 Quince Therapeutics, For: Jun 11 Filed by: Senner Christopher J.
View All Articles

Entities mentioned with QNCX

View All Entities